Condition 1: ?Depression. Condition 2: Anxiety. Depressive episode , unspecifide Anxiety disorder due to known physiological condition
Conditions
Interventions
Intervention 1: "Intervention group:" Menopausal women aged between 45-60 years old referred to Shahid Beheshti University of Medical Sciences, who received 1000 mg (two 500 mg capsules of rose, conta
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Menopausal women aged 45-60 years Having normal blood pressure Not having a historyof BreastCancer, uterine, endometrial hyperplasia, abnormal vaginal bleeding, liver disease, hyperthyroidism Not having a history of hysterectomy or ovariectomy Not having physical (Diabet) or psychiatric illnesses Do not use rose or dried rose extract
Exclusion criteria
Exclusion criteria: Sensitization to herbal medicines Smoking and Alcohol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression Score in Beck Questionnaire. Timepoint: Before the start of the study, 20 days later, 40 days later. Method of measurement: Beck questionnaire.;Anxiety Scale in the Spielberg Burner Questionnaire. Timepoint: Before the start of the study, 20 days later, 40 days later. Method of measurement: Spielberger questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality score. Timepoint: At the beginning of the study, 20 days later, 40 days after starting the dose. Method of measurement: Quality of Life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactQamar Riazi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed